Risk Factors and Predictors of 1-year Overall Mortality in Patients with COVID-19
S. Surme, G. Tuncer, O. Bayramlar, Hindirin Takak, B. Copur, M. Yazla, E. Zerdali, İnci Yılmaz Nakir, G. Sengoz, F. Pehlivanoğlu
{"title":"Risk Factors and Predictors of 1-year Overall Mortality in Patients with COVID-19","authors":"S. Surme, G. Tuncer, O. Bayramlar, Hindirin Takak, B. Copur, M. Yazla, E. Zerdali, İnci Yılmaz Nakir, G. Sengoz, F. Pehlivanoğlu","doi":"10.4274/haseki.galenos.2022.8501","DOIUrl":null,"url":null,"abstract":"Aim: To date, limited data exists on 1-year mortality and associated factors in patients with coronavirus diseases-2019 (COVID-19). We determined risk factors and predictors of 1-year mortality. Method(s): In this retrospective and single-center study, hospitalized patients with COVID-19 were enrolled between March 11 and March 11, 2020. The primary outcome was 1-year all-cause mortality after discharge from the hospital. Secondary outcomes were the risk factors and predictors of 1-year mortality. A comparative analysis was applied to patients who died after recovering from acute COVID-19 and patients who survived. Result(s): A total of 567 patients were analyzed. The 1-year mortality occurred in 18 (3.2%) patients. Older age (p=0.001), chronic obstructive pulmonary disease (p=0.001), chronic artery disease (p=0.001), chronic renal failure (p=0.001), presence of pleural fluid (p=0.001), high levels of leukocyte (p=0.001), neutrophil (p=0.001), monocyte (p=0.026), C-reactive protein (p=0.042), procalcitonin (p=0.004), urea (p=0.001), creatinine (p=0.001), troponin (p=0.001), lactate dehydrogenase (p=0.019), potassium (p=0.003), and a low level of alanine aminotransferase (p=0.001) at the first admission were associated with increased long-term mortality. Additionally, the need for intensive care unit (ICU) admission (p=0.007) and invasive ventilation (p=0.019) during the hospital stay for COVID-19 were associated with increased 1-year mortality. Conclusion(s): This study suggests that age, underlying diseases, pleural fluid, certain laboratory parameters, and ICU care are somewhat associated with 1-year mortality. Copyright © 2022 by The Medical Bulletin of Istanbul Haseki Training and Research Hospital The Medical Bulletin of Haseki published by Galenos Yayinevi.","PeriodicalId":42416,"journal":{"name":"Haseki TIp Bulteni-Medical Bulletin of Haseki","volume":"76 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haseki TIp Bulteni-Medical Bulletin of Haseki","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/haseki.galenos.2022.8501","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To date, limited data exists on 1-year mortality and associated factors in patients with coronavirus diseases-2019 (COVID-19). We determined risk factors and predictors of 1-year mortality. Method(s): In this retrospective and single-center study, hospitalized patients with COVID-19 were enrolled between March 11 and March 11, 2020. The primary outcome was 1-year all-cause mortality after discharge from the hospital. Secondary outcomes were the risk factors and predictors of 1-year mortality. A comparative analysis was applied to patients who died after recovering from acute COVID-19 and patients who survived. Result(s): A total of 567 patients were analyzed. The 1-year mortality occurred in 18 (3.2%) patients. Older age (p=0.001), chronic obstructive pulmonary disease (p=0.001), chronic artery disease (p=0.001), chronic renal failure (p=0.001), presence of pleural fluid (p=0.001), high levels of leukocyte (p=0.001), neutrophil (p=0.001), monocyte (p=0.026), C-reactive protein (p=0.042), procalcitonin (p=0.004), urea (p=0.001), creatinine (p=0.001), troponin (p=0.001), lactate dehydrogenase (p=0.019), potassium (p=0.003), and a low level of alanine aminotransferase (p=0.001) at the first admission were associated with increased long-term mortality. Additionally, the need for intensive care unit (ICU) admission (p=0.007) and invasive ventilation (p=0.019) during the hospital stay for COVID-19 were associated with increased 1-year mortality. Conclusion(s): This study suggests that age, underlying diseases, pleural fluid, certain laboratory parameters, and ICU care are somewhat associated with 1-year mortality. Copyright © 2022 by The Medical Bulletin of Istanbul Haseki Training and Research Hospital The Medical Bulletin of Haseki published by Galenos Yayinevi.
COVID-19患者1年总死亡率的危险因素和预测因素
迄今为止,关于2019冠状病毒病(COVID-19)患者1年死亡率及相关因素的数据有限。我们确定了1年死亡率的危险因素和预测因素。方法:在这项回顾性单中心研究中,纳入2020年3月11日至3月11日住院的COVID-19患者。主要结局是出院后1年的全因死亡率。次要结局是1年死亡率的危险因素和预测因素。对比分析了急性COVID-19康复后死亡的患者和存活的患者。结果:共分析567例患者。1年死亡率为18例(3.2%)。老年(p=0.001)、慢性阻塞性肺病(p=0.001)、慢性动脉疾病(p=0.001)、慢性肾衰竭(p=0.001)、胸膜积液(p=0.001)、白细胞(p=0.001)、中性粒细胞(p=0.001)、单核细胞(p=0.026)、c反应蛋白(p=0.042)、降钙素原(p=0.004)、尿素(p=0.001)、肌酐(p=0.001)、肌钙蛋白(p=0.001)、乳酸脱氢酶(p=0.019)、钾(p=0.003)、首次入院时低水平的丙氨酸转氨酶(p=0.001)与长期死亡率增加相关。此外,因COVID-19住院期间需要重症监护病房(ICU) (p=0.007)和有创通气(p=0.019)与1年死亡率增加相关。结论:本研究提示年龄、基础疾病、胸腔积液、某些实验室参数和ICU护理与1年死亡率有一定关系。伊斯坦布尔Haseki培训和研究医院医学公报版权所有©2022。Galenos Yayinevi出版的Haseki医学公报。
本文章由计算机程序翻译,如有差异,请以英文原文为准。